FDA Insight: Health Fraud and COVID-19

Home
FDA Insight: Health Fraud and COVID-19

August 21, 2020 U.S. Food and Drug Administration

Tweet

Dr. Judy McMeekin, the Associate Commissioner for Regulatory Affairs, joins Dr. Shah on the show to discuss FDA's fight against health fraud during the COVID-19 pandemic.

Click here to listen.

Join Dr. Anand Shah, FDA’s Deputy Commissioner for Medical and Scientific Affairs, and other FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics.

FDA Insight: Advisory Committee on COVID-19 Vaccines October 23, 2020
Virtual Town Hall Series - Coronavirus Test Development and Validation October 23, 2020
Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation October 09, 2020
FDA Insight: Anti-Microbial Resistance October 09, 2020
FDA Insight: The Opioid Epidemic and COVID-19 Pandemic September 18, 2020

FDA Insight: Advisory Committee on COVID-19 Vaccines October 23, 2020
Virtual Town Hall Series - Coronavirus Test Development and Validation October 23, 2020
Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation October 09, 2020
FDA Insight: Anti-Microbial Resistance October 09, 2020
FDA Insight: The Opioid Epidemic and COVID-19 Pandemic September 18, 2020

Posts by Tag

CDC LOCS (4)

Search Blog:

Careers | Press Room

9881 Broken Land Pkwy Suite 200 | Columbia, MD 21046-3016
Phone (800) 981-9883 | Fax (410) 381-8611 | Email info@cola.org